Probiotic lactobacilli as a promising strategy to ameliorate disorders associated with intestinal inflammation induced by a non-steroidal anti-inflammatory drug
Abstract Damage to the small intestine caused by non-steroidal anti-inflammatory drugs (NSAIDs) occurs more frequently than in the upper gastrointestinal tract, is more difficult to diagnose and no effective treatments exist. Hence, we investigated whether probiotics can control the onset of this se...
Main Authors: | María José Martínez Monteros, Carolina Maldonado Galdeano, María Florencia Balcells, Ricardo Weill, Juan Andrés De Paula, Gabriela Perdigón, Silvia Inés Cazorla |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-80482-z |
Similar Items
-
Probiotic Consumption Boosts Thymus in Obesity and Senescence Mouse Models
by: Florencia Balcells, et al.
Published: (2022-01-01) -
Oral Administration of Probiotics Increases Paneth Cells and Intestinal Antimicrobial Activity
by: Silvia I. Cazorla, et al.
Published: (2018-04-01) -
Evaluation of <i>Rouxiella badensis</i> Subsp <i>Acadiensis</i> (Canan SV-53) as a Potential Probiotic Bacterium
by: Ivanna Novotny-Nuñez, et al.
Published: (2023-05-01) -
Biological Properties and Probiotic Potential of Intestinal Lactobacilli
by: Ekaterina A. Borovkova, et al.
Published: (2019-04-01) -
Ameliorative Effect of Surface Proteins of Probiotic Lactobacilli in Colitis Mouse Models
by: P. R. Chandhni, et al.
Published: (2021-09-01)